A detailed history of First Light Asset Management, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, First Light Asset Management, LLC holds 1,320,172 shares of XENE stock, worth $51.5 Million. This represents 4.45% of its overall portfolio holdings.

Number of Shares
1,320,172
Previous 1,645,490 19.77%
Holding current value
$51.5 Million
Previous $75.8 Million 25.01%
% of portfolio
4.45%
Previous 6.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$42.66 - $50.04 $13.9 Million - $16.3 Million
-325,318 Reduced 19.77%
1,320,172 $56.8 Million
Q4 2023

Feb 14, 2024

BUY
$28.7 - $46.46 $37.5 Million - $60.7 Million
1,306,844 Added 385.9%
1,645,490 $75.8 Million
Q2 2023

Aug 14, 2023

BUY
$34.84 - $43.54 $2.06 Million - $2.58 Million
59,202 Added 21.19%
338,646 $13 Million
Q1 2023

May 15, 2023

BUY
$33.46 - $40.35 $9.35 Million - $11.3 Million
279,444 New
279,444 $10 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.43B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.